Microbial cell membrane phospholipids and surface proteins

Microbial cell membrane phospholipids and surface proteins constitute the essential structural and functional barrier of bacteria, fungi, and other microorganisms. These components maintain cellular homeostasis by regulating the transport of ions and nutrients while providing a scaffold for vital enzymatic processes such as cell wall synthesis and energy production (Nature Reviews Microbiology, 2017). In pathogenic microbes, these structures are critical for survival within the host and often harbor virulence factors that facilitate adhesion and immune evasion. Many antimicrobial agents, including polymyxins and daptomycin, specifically target the unique composition of microbial membranes—such as the presence of negatively charged phospholipids like phosphatidylglycerol—to induce membrane depolarization or pore formation (PubMed, PMID: 29439581). This disruption leads to the rapid leakage of essential intracellular contents and subsequent cell death. However, the similarity between certain microbial and mammalian membrane components can lead to off-target toxicity, posing a significant challenge in drug development (PubMed, PMID: 31034602).

Other names

Bacterial cell membraneFungal cell membraneMicrobial envelope componentsProkaryotic cytoplasmic membrane

Drugs targeting these components typically act through membrane disruption, pore formation, or depolarization. Polymyxins bind to lipopolysaccharides and phospholipids in the outer and inner membranes of Gram-negative bacteria, leading to increased permeability and cell death (StatPearls, 2023). Daptomycin inserts into the cytoplasmic membrane of Gram-positive bacteria in a calcium-dependent manner, causing rapid depolarization and loss of membrane potential (PubMed, PMID: 14744331). Antifungals like Amphotericin B bind to ergosterol, a specific fungal membrane sterol, creating pores that cause leakage of intracellular ions (NCBI, 2022).